Stock Markets
NB Bancorp CFO Increases Stake with 1,000-Share Purchase
Jean-Pierre Lapointe, the Chief Financial Officer of NB Bancorp, has acquired an additional 1,000 shares of the company's stock.
JPMorgan Chase Boosts Syndax Pharmaceuticals Price Target to $45
Wall Street firm sees 85% upside potential for biotech stock
Fieldview Capital Management Invests $5.34M in Boston Scientific
The hedge fund purchased 54,715 shares of the medical equipment provider's stock.
Corporate Finance
Editas Reports Q4 Earnings Beat
Genome editing company exceeds Wall Street expectations
GENFIT Reports Strong 2025 Financials, Highlights Pipeline Progress
Biopharmaceutical company sees revenue growth, cash runway through 2028 as key programs advance
Bain Capital Specialty Finance Announces Q4 2025 Results
Dividend covered as Q4 NII hits $0.46 per share, with NAV at $17.23 and only 0.8% of loans on non-accrual
Personal Finance
Vestcor Inc Grows Holdings in Vertex Pharmaceuticals Incorporated
Pharmaceutical company Vertex sees increased investment from Vestcor Inc.
Rhenman & Partners Asset Management AB Boosts Biogen Stake by 358%
The investment firm now owns $7.7 million in shares of the biotechnology company.
Prevail Innovative Wealth Advisors Boosts Vertex Pharmaceuticals Stake
The firm purchased 15,200 additional shares of the biotech company in the third quarter.
- Prosecutors to Drop Domestic Assault Charge Against Patriots' Christian Barmore
- Red Sox Trim Roster, Signaling Trends in Modern Baseball Development
- 8th Child Dies in Massachusetts Flu Season
- Boston College Fires Basketball Coach Earl Grant After 5 Seasons
- Celtics Lose Key Bench Players Ahead of Spurs Matchup
- Jayson Tatum, Celtics Rise In Brand New Power Rankings From NBA.com
